AGENT FOR IMPROVING DEFECTIVE STRUCTURE OF PROTEOLIPID PROTEIN 1, AND AGENT FOR PREVENTION OR TREATMENT OF DISEASE OR SYMPTOM CAUSED BY DEFECTIVE STRUCTURE OF PROTEOLIPID PROTEIN 1, AND USE THEREFOR

摘要

To provide means for substantially improving a defective structure of proteolipid protein 1 (PLP1).SOLUTION: A agent for improving a defective structure of proteolipid protein 1(PLP1) contains a compound represented by formula (I-1-1) or (I-2-1), its stereoisomer or a salt thereof, or their solvates as active ingredients. There is also provided a pharmaceutical composition used for prevention or treatment of a disease or symptom caused by a defective structure of PLP1, containing the compound, its stereoisomer or a pharmaceutically acceptable salt thereof as an active ingredient.SELECTED DRAWING: None